Logo image of SUM

Summit Materials Inc (SUM) Stock Fundamental Analysis

USA - NYSE:SUM - US86614U1007 - Common Stock

52.49 USD
+0.04 (+0.08%)
Last: 2/10/2025, 8:24:42 PM
52.55 USD
+0.06 (+0.11%)
After Hours: 2/10/2025, 8:24:42 PM
Fundamental Rating

4

Overall SUM gets a fundamental rating of 4 out of 10. We evaluated SUM against 13 industry peers in the Construction Materials industry. SUM has an average financial health and profitability rating. SUM shows excellent growth, but is valued quite expensive already.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

SUM had positive earnings in the past year.
SUM had a positive operating cash flow in the past year.
Each year in the past 5 years SUM has been profitable.
Each year in the past 5 years SUM had a positive operating cash flow.
SUM Yearly Net Income VS EBIT VS OCF VS FCFSUM Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 100M 200M 300M 400M

1.2 Ratios

With a Return On Assets value of 1.75%, SUM is not doing good in the industry: 91.67% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of 3.31%, SUM is doing worse than 91.67% of the companies in the same industry.
SUM's Return On Invested Capital of 4.51% is on the low side compared to the rest of the industry. SUM is outperformed by 91.67% of its industry peers.
SUM had an Average Return On Invested Capital over the past 3 years of 4.89%. This is significantly below the industry average of 10.33%.
Industry RankSector Rank
ROA 1.75%
ROE 3.31%
ROIC 4.51%
ROA(3y)5.18%
ROA(5y)4.04%
ROE(3y)11.46%
ROE(5y)9.43%
ROIC(3y)4.89%
ROIC(5y)4.65%
SUM Yearly ROA, ROE, ROICSUM Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2 4 6 8 10

1.3 Margins

With a Profit Margin value of 3.92%, SUM is not doing good in the industry: 83.33% of the companies in the same industry are doing better.
SUM's Profit Margin has improved in the last couple of years.
The Operating Margin of SUM (12.64%) is worse than 66.67% of its industry peers.
SUM's Operating Margin has improved in the last couple of years.
SUM has a Gross Margin (29.81%) which is in line with its industry peers.
SUM's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 12.64%
PM (TTM) 3.92%
GM 29.81%
OM growth 3Y10.44%
OM growth 5Y8.05%
PM growth 3Y22.64%
PM growth 5Y46.57%
GM growth 3Y2.73%
GM growth 5Y-0.58%
SUM Yearly Profit, Operating, Gross MarginsSUM Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 10 20 30

More info and screens

4

2. Health

2.1 Basic Checks

SUM has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
The number of shares outstanding for SUM has been increased compared to 1 year ago.
The number of shares outstanding for SUM has been increased compared to 5 years ago.
The debt/assets ratio for SUM is higher compared to a year ago.
SUM Yearly Shares OutstandingSUM Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 20M 40M 60M 80M 100M
SUM Yearly Total Debt VS Total AssetsSUM Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B 4B 5B

2.2 Solvency

SUM has an Altman-Z score of 2.36. This is not the best score and indicates that SUM is in the grey zone with still only limited risk for bankruptcy at the moment.
SUM has a Altman-Z score (2.36) which is in line with its industry peers.
The Debt to FCF ratio of SUM is 16.66, which is on the high side as it means it would take SUM, 16.66 years of fcf income to pay off all of its debts.
Looking at the Debt to FCF ratio, with a value of 16.66, SUM is doing worse than 75.00% of the companies in the same industry.
SUM has a Debt/Equity ratio of 0.63. This is a neutral value indicating SUM is somewhat dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.63, SUM is doing worse than 83.33% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 16.66
Altman-Z 2.36
ROIC/WACC0.51
WACC8.78%
SUM Yearly LT Debt VS Equity VS FCFSUM Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 500M 1B 1.5B 2B

2.3 Liquidity

SUM has a Current Ratio of 3.10. This indicates that SUM is financially healthy and has no problem in meeting its short term obligations.
Looking at the Current ratio, with a value of 3.10, SUM belongs to the top of the industry, outperforming 91.67% of the companies in the same industry.
SUM has a Quick Ratio of 2.48. This indicates that SUM is financially healthy and has no problem in meeting its short term obligations.
SUM's Quick ratio of 2.48 is amongst the best of the industry. SUM outperforms 91.67% of its industry peers.
Industry RankSector Rank
Current Ratio 3.1
Quick Ratio 2.48
SUM Yearly Current Assets VS Current LiabilitesSUM Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B

More info and screens

8

3. Growth

3.1 Past

The Earnings Per Share has been growing slightly by 1.27% over the past year.
SUM shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 59.94% yearly.
Looking at the last year, SUM shows a very strong growth in Revenue. The Revenue has grown by 49.48%.
SUM shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 4.51% yearly.
EPS 1Y (TTM)1.27%
EPS 3Y24.17%
EPS 5Y59.94%
EPS Q2Q%-7.41%
Revenue 1Y (TTM)49.48%
Revenue growth 3Y3.94%
Revenue growth 5Y4.51%
Sales Q2Q%47.35%

3.2 Future

Based on estimates for the next years, SUM will show a very strong growth in Earnings Per Share. The EPS will grow by 25.33% on average per year.
The Revenue is expected to grow by 24.77% on average over the next years. This is a very strong growth
EPS Next Y10.65%
EPS Next 2Y22.95%
EPS Next 3Y25.33%
EPS Next 5YN/A
Revenue Next Year64.9%
Revenue Next 2Y33.36%
Revenue Next 3Y24.77%
Revenue Next 5YN/A

3.3 Evolution

The estimated forward EPS growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
SUM Yearly Revenue VS EstimatesSUM Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1B 2B 3B 4B
SUM Yearly EPS VS EstimatesSUM Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 1 2 3

More info and screens

2

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 32.81, SUM can be considered very expensive at the moment.
SUM's Price/Earnings ratio is a bit more expensive when compared to the industry. SUM is more expensive than 75.00% of the companies in the same industry.
SUM's Price/Earnings ratio indicates a valuation a bit more expensive than the S&P500 average which is at 27.32.
The Price/Forward Earnings ratio is 22.12, which indicates a rather expensive current valuation of SUM.
66.67% of the companies in the same industry are more expensive than SUM, based on the Price/Forward Earnings ratio.
When comparing the Price/Forward Earnings ratio of SUM to the average of the S&P500 Index (22.89), we can say SUM is valued inline with the index average.
Industry RankSector Rank
PE 32.81
Fwd PE 22.12
SUM Price Earnings VS Forward Price EarningsSUM Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

SUM's Enterprise Value to EBITDA is on the same level as the industry average.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of SUM indicates a slightly more expensive valuation: SUM is more expensive than 66.67% of the companies listed in the same industry.
Industry RankSector Rank
P/FCF 54.44
EV/EBITDA 13.43
SUM Per share dataSUM EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 5 10 15 20 25

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
A more expensive valuation may be justified as SUM's earnings are expected to grow with 25.33% in the coming years.
PEG (NY)3.08
PEG (5Y)0.55
EPS Next 2Y22.95%
EPS Next 3Y25.33%

More info and screens

0

5. Dividend

5.1 Amount

No dividends for SUM!.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Summit Materials Inc

NYSE:SUM (2/10/2025, 8:24:42 PM)

After market: 52.55 +0.06 (+0.11%)

52.49

+0.04 (+0.08%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryConstruction Materials
Earnings (Last)02-13 2025-02-13/amc
Earnings (Next)04-29 2025-04-29/amc
Inst Owners65.2%
Inst Owner Change-18.25%
Ins OwnersN/A
Ins Owner Change0%
Market Cap9.23B
Analysts70.53
Price Target50.1 (-4.55%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)6.89%
Min EPS beat(2)6.65%
Max EPS beat(2)7.13%
EPS beat(4)4
Avg EPS beat(4)19.52%
Min EPS beat(4)6.65%
Max EPS beat(4)48.07%
EPS beat(8)8
Avg EPS beat(8)18.03%
EPS beat(12)10
Avg EPS beat(12)12.07%
EPS beat(16)13
Avg EPS beat(16)13.68%
Revenue beat(2)0
Avg Revenue beat(2)-4.78%
Min Revenue beat(2)-5.63%
Max Revenue beat(2)-3.93%
Revenue beat(4)1
Avg Revenue beat(4)-0.73%
Min Revenue beat(4)-5.63%
Max Revenue beat(4)11.01%
Revenue beat(8)4
Avg Revenue beat(8)-0.21%
Revenue beat(12)6
Avg Revenue beat(12)0.01%
Revenue beat(16)9
Avg Revenue beat(16)2.46%
PT rev (1m)-6.66%
PT rev (3m)-7.35%
EPS NQ rev (1m)1.5%
EPS NQ rev (3m)1.5%
EPS NY rev (1m)1.99%
EPS NY rev (3m)1.99%
Revenue NQ rev (1m)-0.85%
Revenue NQ rev (3m)-0.75%
Revenue NY rev (1m)-0.14%
Revenue NY rev (3m)0.02%
Valuation
Industry RankSector Rank
PE 32.81
Fwd PE 22.12
P/S 2.46
P/FCF 54.44
P/OCF 17.11
P/B 2.08
P/tB 4.16
EV/EBITDA 13.43
EPS(TTM)1.6
EY3.05%
EPS(NY)2.37
Fwd EY4.52%
FCF(TTM)0.96
FCFY1.84%
OCF(TTM)3.07
OCFY5.85%
SpS21.36
BVpS25.29
TBVpS12.63
PEG (NY)3.08
PEG (5Y)0.55
Profitability
Industry RankSector Rank
ROA 1.75%
ROE 3.31%
ROCE 6.03%
ROIC 4.51%
ROICexc 4.98%
ROICexgc 7.24%
OM 12.64%
PM (TTM) 3.92%
GM 29.81%
FCFM 4.51%
ROA(3y)5.18%
ROA(5y)4.04%
ROE(3y)11.46%
ROE(5y)9.43%
ROIC(3y)4.89%
ROIC(5y)4.65%
ROICexc(3y)5.44%
ROICexc(5y)5.16%
ROICexgc(3y)8.1%
ROICexgc(5y)7.79%
ROCE(3y)6.53%
ROCE(5y)6.21%
ROICexcg growth 3Y3.53%
ROICexcg growth 5Y5.58%
ROICexc growth 3Y6.61%
ROICexc growth 5Y7.42%
OM growth 3Y10.44%
OM growth 5Y8.05%
PM growth 3Y22.64%
PM growth 5Y46.57%
GM growth 3Y2.73%
GM growth 5Y-0.58%
F-Score6
Asset Turnover0.45
Health
Industry RankSector Rank
Debt/Equity 0.63
Debt/FCF 16.66
Debt/EBITDA 3.33
Cap/Depr 100.52%
Cap/Sales 9.85%
Interest Coverage 3.17
Cash Conversion 64.03%
Profit Quality 115.02%
Current Ratio 3.1
Quick Ratio 2.48
Altman-Z 2.36
F-Score6
WACC8.78%
ROIC/WACC0.51
Cap/Depr(3y)109.47%
Cap/Depr(5y)97.16%
Cap/Sales(3y)9.87%
Cap/Sales(5y)9.04%
Profit Quality(3y)56.33%
Profit Quality(5y)121.42%
High Growth Momentum
Growth
EPS 1Y (TTM)1.27%
EPS 3Y24.17%
EPS 5Y59.94%
EPS Q2Q%-7.41%
EPS Next Y10.65%
EPS Next 2Y22.95%
EPS Next 3Y25.33%
EPS Next 5YN/A
Revenue 1Y (TTM)49.48%
Revenue growth 3Y3.94%
Revenue growth 5Y4.51%
Sales Q2Q%47.35%
Revenue Next Year64.9%
Revenue Next 2Y33.36%
Revenue Next 3Y24.77%
Revenue Next 5YN/A
EBIT growth 1Y50.79%
EBIT growth 3Y14.79%
EBIT growth 5Y12.92%
EBIT Next Year197.56%
EBIT Next 3Y54.11%
EBIT Next 5YN/A
FCF growth 1Y203.77%
FCF growth 3Y-7.52%
FCF growth 5YN/A
OCF growth 1Y88.16%
OCF growth 3Y2.38%
OCF growth 5Y15.95%